TRAWS PHARMA, INC.
COM · CUSIP 682CVR055
1
institutional holders
+0 vs Q4 2024
5.1k
shares reported held*
$1reported value*
1 new
0 added
0 reduced
1 sold out
net bought ≈ $1 (+5.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.00.
Trends to Q1 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2024 | 1 |
| Q3 2024 | 1 |
| Q4 2024 | 1 |
| Q1 2025 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 0 | 0 |
| Q4 2024 | 0 | 0 |
| Q1 2025 | 1 | 1 |
Biggest buyers
Biggest sellers
| Towne Trust Company, N.A | Sold out | -166 |
Holders, Q1 2025
| Manager | Shares | Change |
|---|---|---|
| Vermillion & White Wealth Management Group, LLC 0.00% of their portfolio | 5.1k $1 | New |